Citation Impact

2 standout

Citing Papers

Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
2022 Standout
1 intermediate paper

Works of Anna Wall being referenced

International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI
2020

Author Peers

Author PFM PRM Oncology Genetics Last Decade Papers Cites
Anna Wall 169 31 95 50 7 209
H. Saneoka 3 17 780
Timur I. Burganov 13 40 572
Shanting Hao 10 339
Bongki Shin 41 14 396
K.K. Bissada 1 16 334

All Works

Loading papers...

Rankless by CCL
2026